For instance, VEGF is a well-known factor that can alter EC junctional proteins to disrupt iBRB integrity in retinal vascular diseases in part through protein kinase C (PKC), and both VEGF and PKC are common drug targets in diabetic retinopathy and diabetic macular edema (DME) [143]. The gene discussed is PRRT2; the disease is diabetic macular edema.